Outset Medical will present at the Morgan Stanley Global Healthcare Conference on Sept. 10, 2025.
Quiver AI Summary
Outset Medical, Inc., a pioneering medical technology company focused on simplifying dialysis, announced that its management will present at the Morgan Stanley Global Healthcare Conference on September 10, 2025, at 7 a.m. Eastern time, with a webcast available on their website. The company is known for its innovative Tablo® Hemodialysis System, which is FDA-cleared for use in various healthcare settings from hospitals to home care. Trusted by over 1,000 healthcare facilities in the U.S., Tablo integrates water purification and on-demand dialysate production in a single system, enhancing operational and clinical outcomes through its connectivity with Electronic Medical Records and a proprietary data analytics platform. Outset continues to redefine kidney care by enhancing treatment experiences for patients and healthcare professionals alike.
Potential Positives
- Outset Medical will present at the prestigious Morgan Stanley Global Healthcare Conference, showcasing its advancements and gaining visibility in the healthcare sector.
- The Tablo® Hemodialysis System, a first-of-its-kind technology, has been adopted by over 1,000 healthcare facilities, indicating strong market acceptance and trust in the product.
- The company's innovative technology aims to significantly reduce the cost and complexity of dialysis, which could enhance patient outcomes and operational efficiencies for healthcare providers.
- Outset's approach integrates seamlessly with Electronic Medical Records and includes a proprietary data analytics platform, positioning the company as a leader in modernizing kidney care.
Potential Negatives
- None
FAQ
What is the presentation date for Outset Medical at the Morgan Stanley Healthcare Conference?
The presentation will take place on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.
Where can I watch the Outset Medical presentation live?
The live presentation can be viewed on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
What technology does Outset Medical focus on?
Outset Medical specializes in technology that reduces the cost and complexity of dialysis, particularly with its Tablo® Hemodialysis System.
How does the Tablo® Hemodialysis System work?
The Tablo system combines water purification and on-demand dialysate production into one integrated system for seamless dialysis.
What impact has the Tablo® system had on healthcare facilities?
More than 1,000 U.S. healthcare facilities trust Tablo, which has enabled millions of treatments delivered by thousands of nurses.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OM Insider Trading Activity
$OM insiders have traded $OM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $OM stock by insiders over the last 6 months:
- LESLIE TRIGG (Chair and CEO) has made 0 purchases and 2 sales selling 1,839 shares for an estimated $28,286.
- JOHN L. BROTTEM (General Counsel) has made 0 purchases and 2 sales selling 779 shares for an estimated $11,989.
- NABEEL AHMED (Chief Financial Officer) sold 584 shares for an estimated $10,401
- MARC NASH (SVP Operations and R&D) has made 0 purchases and 2 sales selling 495 shares for an estimated $7,620.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OM Hedge Fund Activity
We have seen 2 institutional investors add shares of $OM stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OSAIC HOLDINGS, INC. added 366 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,030
- ACCENT CAPITAL MANAGEMENT, LLC added 150 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,881
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23 rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/ .
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo
®
Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit
www.outsetmedical.com
.
Contact
Jim Mazzola
Investor Relations
[email protected]
